Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00020527 · ClinicalTrials.gov registry record · NA
Caspofungin Acetate in Treating Children With Fever and Neutropenia
A NA study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- NA
- Development phase
NCT00020527: Completed NA study, sponsored by National Cancer Institute (NCI).
NCT00020527 is a NA study that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00020527, a NA study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Giving caspofungin acetate may be effective in preventing or controlling fever and neutropenia caused by chemotherapy or bone marrow transplantation. PURPOSE: Clinical trial to study the effectiveness of caspofungin acetate in treating children who have fever and neutropenia caused by a weakened immune system.
Interventions
- DRUG caspofungin acetate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-03 |
| Est. Completion | 2003-06 |
| Phase | NA |
What the finished NCT00020527 record still lists
NCT00020527 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which caspofungin acetate is the first listed.
NCT00020527 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00020527 about?
NCT00020527 is a clinical study titled "Caspofungin Acetate in Treating Children With Fever and Neutropenia". RATIONALE: Giving caspofungin acetate may be effective in preventing or controlling fever and neutropenia caused by chemotherapy or bone marrow transplantation. PURPOSE: Clinical trial to study the effectiveness of caspofungin acetate in treating children who have fever and neutropenia caused by a ...
What is the current status of trial NCT00020527?
This trial is currently completed. It is a NA study. The study started on 2001-03. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00020527?
The interventions under investigation include: caspofungin acetate (DRUG).
Who is sponsoring clinical trial NCT00020527?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia